Annual EBITDA
-$15.19 M
-$10.13 M-200.24%
December 31, 2023
Summary
- As of February 12, 2025, CTCX annual EBITDA is -$15.19 million, with the most recent change of -$10.13 million (-200.24%) on December 31, 2023.
- During the last 3 years, CTCX annual EBITDA has fallen by -$11.45 million (-306.43%).
- CTCX annual EBITDA is now -306.43% below its all-time high of -$3.74 million, reached on December 31, 2021.
Performance
CTCX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.83 M
+$408.40 K+12.62%
September 30, 2024
Summary
- As of February 12, 2025, CTCX quarterly EBITDA is -$2.83 million, with the most recent change of +$408.40 thousand (+12.62%) on September 30, 2024.
- Over the past year, CTCX quarterly EBITDA has increased by +$5.88 million (+67.52%).
- CTCX quarterly EBITDA is now -4158.11% below its all-time high of $69.70 thousand, reached on December 31, 2023.
Performance
CTCX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$9.47 M
+$5.88 M+38.31%
September 30, 2024
Summary
- As of February 12, 2025, CTCX TTM EBITDA is -$9.47 million, with the most recent change of +$5.88 million (+38.31%) on September 30, 2024.
- Over the past year, CTCX TTM EBITDA has increased by +$8.45 million (+47.15%).
- CTCX TTM EBITDA is now -3211.05% below its all-time high of -$285.90 thousand, reached on June 30, 2022.
Performance
CTCX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CTCX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -200.2% | +67.5% | +47.1% |
| 3 y3 years | -306.4% | -3.7% | -25.1% |
| 5 y5 years | -306.4% | -3.7% | -25.1% |
CTCX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -306.4% | at low | -4158.1% | +67.5% | -3211.1% | +47.1% |
| 5 y | 5-year | -306.4% | at low | -4158.1% | +67.5% | -3211.1% | +47.1% |
| alltime | all time | -306.4% | at low | -4158.1% | +67.5% | -3211.1% | +47.1% |
Carmell Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.83 M(-12.6%) | -$9.47 M(-38.3%) |
| Jun 2024 | - | -$3.24 M(-6.7%) | -$15.35 M(-10.2%) |
| Mar 2024 | - | -$3.47 M(-5079.3%) | -$17.08 M(+13.0%) |
| Dec 2023 | -$15.19 M | $69.70 K(-100.8%) | -$15.11 M(-15.6%) |
| Sep 2023 | - | -$8.71 M(+75.2%) | -$17.91 M(+30.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$4.97 M(+230.2%) | -$13.76 M(+51.6%) |
| Mar 2023 | - | -$1.51 M(-44.8%) | -$9.07 M(+19.9%) |
| Dec 2022 | -$5.06 M(+35.4%) | -$2.73 M(-40.1%) | -$7.57 M(+56.4%) |
| Sep 2022 | - | -$4.55 M(+1491.9%) | -$4.84 M(+1591.9%) |
| Jun 2022 | - | -$285.90 K | -$285.90 K |
| Dec 2021 | -$3.74 M | - | - |
FAQ
- What is Carmell Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Carmell Therapeutics?
- What is Carmell Therapeutics annual EBITDA year-on-year change?
- What is Carmell Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly EBITDA year-on-year change?
- What is Carmell Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Carmell Therapeutics?
- What is Carmell Therapeutics TTM EBITDA year-on-year change?
What is Carmell Therapeutics annual EBITDA?
The current annual EBITDA of CTCX is -$15.19 M
What is the all time high annual EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high annual EBITDA is -$3.74 M
What is Carmell Therapeutics annual EBITDA year-on-year change?
Over the past year, CTCX annual EBITDA has changed by -$10.13 M (-200.24%)
What is Carmell Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CTCX is -$2.83 M
What is the all time high quarterly EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly EBITDA is $69.70 K
What is Carmell Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CTCX quarterly EBITDA has changed by +$5.88 M (+67.52%)
What is Carmell Therapeutics TTM EBITDA?
The current TTM EBITDA of CTCX is -$9.47 M
What is the all time high TTM EBITDA for Carmell Therapeutics?
Carmell Therapeutics all-time high TTM EBITDA is -$285.90 K
What is Carmell Therapeutics TTM EBITDA year-on-year change?
Over the past year, CTCX TTM EBITDA has changed by +$8.45 M (+47.15%)